Published in Int J Stroke on April 01, 2010
Secondary Prevention of Small Subcortical Strokes Trial (SPS3) | NCT00059306
The Secondary Prevention of Small Subcortical Strokes (SPS3) study. Int J Stroke (2011) 2.35
Distinct plasma immune signatures in ME/CFS are present early in the course of illness. Sci Adv (2015) 1.25
Inflammatory mechanisms of stroke. Stroke (2010) 1.06
C-reactive protein as a prognostic marker after lacunar stroke: levels of inflammatory markers in the treatment of stroke study. Stroke (2014) 0.97
Small vessel cerebrovascular disease: the past, present, and future. Stroke Res Treat (2012) 0.92
Discovery of prognostic biomarker candidates of lacunar infarction by quantitative proteomics of microvesicles enriched plasma. PLoS One (2014) 0.87
Xueshuantong improves cerebral blood perfusion in elderly patients with lacunar infarction. Neural Regen Res (2013) 0.81
Numbers of Stroke Patients and Stroke Subtypes According to Highest and Lowest Daily Temperatures in Seoul. J Clin Neurol (2016) 0.75
Inflammatory Markers and Outcomes After Lacunar Stroke: Levels of Inflammatory Markers in Treatment of Stroke Study. Stroke (2016) 0.75
Atherosclerosis--an inflammatory disease. N Engl J Med (1999) 59.28
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med (2008) 43.36
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med (2000) 18.04
Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med (2003) 10.61
Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation (2000) 8.17
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11
Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med (2001) 7.51
A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med (2001) 7.07
Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation (1998) 4.89
Soluble CD40 ligand in acute coronary syndromes. N Engl J Med (2003) 4.06
Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature (1998) 3.31
The Harvard Cooperative Stroke Registry: a prospective registry. Neurology (1978) 3.19
Medical complications after stroke: a multicenter study. Stroke (2000) 2.81
Ischemic stroke subtypes : a population-based study of functional outcome, survival, and recurrence. Stroke (2000) 2.78
Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke (2001) 2.71
C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. Eur Heart J (2000) 2.59
Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation (2004) 2.50
Risk of myocardial infarction or vascular death after first ischemic stroke: the Northern Manhattan Study. Stroke (2007) 2.30
Neuropathologic correlates of white matter hyperintensities. Neurology (2008) 2.29
A high plasma concentration of TNF-alpha is associated with dementia in centenarians. J Gerontol A Biol Sci Med Sci (1999) 2.24
The natural history of lacunar infarction: the Oxfordshire Community Stroke Project. Stroke (1987) 2.24
The leukocyte count as a predictor of myocardial infarction. N Engl J Med (1974) 2.22
Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS Investigators. Stroke (1998) 2.22
Complications after acute stroke. Stroke (1996) 2.21
Expression of functional CD40 by vascular endothelial cells. J Exp Med (1995) 2.16
Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial. JAMA (2001) 2.16
Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation (1997) 2.12
Incidence and case fatality rates of stroke subtypes in a multiethnic population: the South London Stroke Register. J Neurol Neurosurg Psychiatry (2002) 2.02
Tumor necrosis factor receptor levels are associated with carotid atherosclerosis. Stroke (2002) 1.94
Total homocysteine is associated with white matter hyperintensity volume: the Northern Manhattan Study. Stroke (2005) 1.91
Testing the validity of the lacunar hypothesis: the Northern Manhattan Stroke Study experience. Neurology (1997) 1.80
Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke (2001) 1.73
High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke. Arch Intern Med (2006) 1.73
Seropositivity to Chlamydia pneumoniae is associated with risk of first ischemic stroke. Stroke (2006) 1.70
C-reactive protein is a strong but nonspecific risk factor of fatal stroke in elderly persons. Arterioscler Thromb Vasc Biol (2000) 1.70
Leukocyte count, smoking, and myocardial infarction. N Engl J Med (1981) 1.68
Upregulation of CD40-CD40 ligand (CD154) in patients with acute cerebral ischemia. Stroke (2003) 1.61
Clinical determinants of dementia related to stroke. Ann Neurol (1993) 1.58
Elevated white blood cell count and carotid plaque thickness : the northern manhattan stroke study. Stroke (2001) 1.58
von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study. Arterioscler Thromb Vasc Biol (1999) 1.57
Soluble CD40L and cardiovascular risk in women. Circulation (2001) 1.52
The effect of 17 beta-estradiol on MCP-1 serum levels in postmenopausal women. Cardiovasc Res (2002) 1.51
Characterization of risk factors for vascular dementia: the Honolulu-Asia Aging Study. Neurology (1999) 1.44
Inflammation-mediated damage in progressing lacunar infarctions: a potential therapeutic target. Stroke (2002) 1.36
C-reactive protein and the future risk of thromboembolic stroke in healthy men. Circulation (2003) 1.32
Leukocyte counts and coronary heart disease in a Japanese cohort. Am J Epidemiol (1982) 1.32
Soluble CD40L: risk prediction after acute coronary syndromes. Circulation (2003) 1.29
Two types of lacunar infarcts: further arguments from a study on prognosis. Stroke (2002) 1.24
Leukocyte count predicts outcome after ischemic stroke: the Northern Manhattan Stroke Study. J Stroke Cerebrovasc Dis (2007) 1.23
Leukocyte count is associated with reduced endothelial reactivity. Atherosclerosis (2005) 1.21
Clinical study of 227 patients with lacunar infarcts. Stroke (1990) 1.20
Age and duration of follow-up as modulators of the risk for ischemic heart disease associated with high plasma C-reactive protein levels in men. Arch Intern Med (2001) 1.20
Hypertension and diabetes mellitus as determinants of multiple lacunar infarcts. Stroke (1995) 1.18
Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population : Jichi Medical School Cohort Study. Am J Epidemiol (2001) 1.18
Nonhypertensive cerebral small-vessel disease. An autopsy study. Stroke (1997) 1.16
Fever and infection early after ischemic stroke. J Neurol Sci (1999) 1.16
Leukoaraiosis in relation to prognosis for patients with lacunar infarction. Stroke (1992) 1.15
Reliability and validity of blood pressure measurement in the Secondary Prevention of Small Subcortical Strokes study. Blood Press Monit (2007) 1.12
Clinical-computed tomographic correlations of lacunar infarction in the Stroke Data Bank. Stroke (1991) 1.12
A -174G/C polymorphism of the interleukin-6 gene in patients with lacunar infarction. Neurosci Lett (2002) 1.11
The first international standard for serum amyloid A protein (SAA). Evaluation in an international collaborative study. J Immunol Methods (1998) 1.10
Long-term prognosis of first-ever lacunar strokes. A hospital-based study. Stroke (1996) 1.10
C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the Speedwell study: are inflammation and fibrin turnover linked in pathogenesis? Arterioscler Thromb Vasc Biol (2001) 1.08
Suppression of stroke-induced progenitor proliferation in adult subventricular zone by tumor necrosis factor receptor 1. J Cereb Blood Flow Metab (2008) 1.05
Monocyte chemoattractant protein-1 and coronary artery disease. Clin Cardiol (2002) 1.04
Serum C-reactive protein and self-reported stroke: findings from the Third National Health and Nutrition Examination Survey. Arterioscler Thromb Vasc Biol (2000) 1.03
Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy. J Am Coll Cardiol (2000) 0.98
Impact of race and ethnicity on ischemic stroke. The University of California at San Diego Stroke Data Bank. Stroke (1995) 0.98
Ligation of CD40 activates interleukin 1beta-converting enzyme (caspase-1) activity in vascular smooth muscle and endothelial cells and promotes elaboration of active interleukin 1beta. J Biol Chem (1997) 0.94
Distributions of C-reactive protein measured by high-sensitivity assays in apparently healthy men and women from different populations in Europe. Clin Chem (2003) 0.90
An analysis of ischemic stroke in an urban southern California population. The University of California, San Diego, Stroke Data Bank. Arch Intern Med (1993) 0.88
Increased levels of soluble tumor necrosis factor receptors in atherosclerosis: no clear relationship with levels of tumor necrosis factor. Inflammation (1998) 0.87
C-reactive protein (CRP) in cerebro-vascular events. Atherosclerosis (1999) 0.82
Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med (1999) 7.74
Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study. Am J Epidemiol (1998) 5.54
Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. Lancet (2013) 5.20
Race-ethnic disparities in the impact of stroke risk factors: the northern Manhattan stroke study. Stroke (2001) 4.07
Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem (1993) 3.04
High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan Stroke Study. JAMA (2001) 2.85
How easy is it to contact the duty medical doctor responsible for acute admissions? BMJ (1990) 2.80
Oral treatments for fungal infections of the skin of the foot. Cochrane Database Syst Rev (2002) 2.75
Leisure-time physical activity and ischemic stroke risk: the Northern Manhattan Stroke Study. Stroke (1998) 2.70
The protective effect of moderate alcohol consumption on ischemic stroke. JAMA (1999) 2.68
Modern statistical methods for handling missing repeated measurements in obesity trial data: beyond LOCF. Obes Rev (2003) 2.54
Size and albedo of Kuiper belt object 55636 from a stellar occultation. Nature (2010) 2.49
Multivariate analysis for matched case-control studies. Am J Epidemiol (1978) 2.40
Alzheimer's disease and its Lewy body variant: a clinical analysis of postmortem verified cases. Am J Psychiatry (1996) 2.30
Carotid endarterectomy--an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2005) 2.26
Carotid plaque, a subclinical precursor of vascular events: the Northern Manhattan Study. Neurology (2008) 2.09
Two Cases of Puerperal Anuria in which the Renal Capsule was incised and Portions of the Kidney Substance removed for Examination. Proc R Soc Med (1919) 2.08
Responses of consecutive patients to reassurance after gastroscopy: results of self administered questionnaire survey. BMJ (1997) 2.07
Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators. Circulation (2000) 2.07
Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology (1994) 2.04
Physical activity and risk of ischemic stroke in the Northern Manhattan Study. Neurology (2009) 2.02
Race-ethnicity and determinants of carotid atherosclerosis in a multiethnic population. The Northern Manhattan Stroke Study. Stroke (1997) 2.00
A Foetus with Congenital Hereditary Graves's Disease. Proc R Soc Med (1912) 1.99
Health, fitness, physical activity, and morbidity of middle aged male factory workers. I. Br J Ind Med (1986) 1.93
c-Rel regulates interleukin 12 p70 expression in CD8(+) dendritic cells by specifically inducing p35 gene transcription. J Exp Med (2001) 1.92
Stulberg classification system for evaluation of Legg-Calvé-Perthes disease: intra-rater and inter-rater reliability. J Bone Joint Surg Am (1999) 1.85
An epidemiologic study of epithelial carcinoma of the ovary. Am J Epidemiol (1981) 1.80
Race and survival from breast cancer: based on Cancer and Leukemia Group B trial 8541. Cancer J Sci Am (1997) 1.79
Isolation and characterisation of the RAD51 and DMC1 homologs from Arabidopsis thaliana. Mol Gen Genet (1998) 1.78
The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence: a prospective cohort study. J Clin Endocrinol Metab (2009) 1.77
Randomized trial of thrombolysis versus heparin in unstable angina. Circulation (1992) 1.74
A multicenter study on the use of pulsed low-intensity direct current for healing chronic stage II and stage III decubitus ulcers. Arch Dermatol (1993) 1.68
Microbial treatment of metal pollution--a working biotechnology? Trends Biotechnol (1993) 1.63
Cerebral microbleeds: histopathological correlation of neuroimaging. Cerebrovasc Dis (2011) 1.63
Application of DNA fingerprints for cell-line individualization. Am J Hum Genet (1990) 1.62
New child health tsar promises shake-up of services. BMJ (2001) 1.62
Continuous intravenous infusion of small doses of insulin in treatment of diabetic ketoacidosis. Br Med J (1974) 1.58
Elevated white blood cell count and carotid plaque thickness : the northern manhattan stroke study. Stroke (2001) 1.58
Racial differences in venous thromboembolism. J Thromb Haemost (2011) 1.57
Bone density and osteoporosis: crunching more than numbers. Aust N Z J Med (1997) 1.56
Complications and protocol considerations in carbon monoxide-poisoned patients who require hyperbaric oxygen therapy: report from a ten-year experience. Ann Emerg Med (1989) 1.55
Revisiting extinction in national parks: mountain caribou in Banff. Conserv Biol (2009) 1.53
Potential utility of rubidium 82 PET quantification in patients with 3-vessel coronary artery disease. J Nucl Cardiol (2004) 1.53
Workforce projections for optometry. Optometry (2000) 1.52
Early prescriptions of antibiotics and the risk of allergic disease in adults: a cohort study. Thorax (2004) 1.52
Prediction of tumour volume and pathological stage in radical prostatectomy specimens is not improved by taking more prostate needle-biopsy cores. BJU Int (2001) 1.50
A case-control study of cancer of the endometrium. Am J Epidemiol (1982) 1.50
Vascular risk factors and cognitive impairment in a stroke-free cohort. Neurology (2011) 1.49
Aspirin for the primary prevention of stroke and other major vascular events: meta-analysis and hypotheses. Arch Neurol (2000) 1.49
Usefulness of multislice spiral computed tomography angiography for determination of coronary artery stenoses. Am J Cardiol (2001) 1.47
Cost-effectiveness of additional catheter-directed thrombolysis for deep vein thrombosis. J Thromb Haemost (2013) 1.46
Genitourinary medicine: an opportunity to reduce unwanted pregnancy. Int J STD AIDS (2004) 1.45
Mortality and causes of death after first ischemic stroke: the Northern Manhattan Stroke Study. Neurology (2001) 1.43
Functional characterization of the Bcl-2 gene family in the zebrafish. Cell Death Differ (2006) 1.43
Effect of gender on outcomes following renal artery stent placement for renovascular hypertension. Cathet Cardiovasc Diagn (1997) 1.43
Extracts from "Clinical evidence": Athlete's foot and fungally infected toenails. BMJ (2001) 1.41
Utility of magnetic resonance imaging in a patient with anomalous origin of the right coronary artery, acute myocardial infarction, and near-sudden cardiac death. Cathet Cardiovasc Diagn (1997) 1.40
Volvulus of the Caecum occurring in Connexion with Labour. Proc R Soc Med (1914) 1.38
A Case of Full-time Pregnancy in a Rudimentary Uterine Horn. Proc R Soc Med (1919) 1.38
Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study. Circulation (1998) 1.37
The quality of obstetrical clinical practice guidelines promulgated by a specialty society. J Obstet Gynaecol Can (2002) 1.37
Patients' perceptions and responses to procedural pain: results from Thunder Project II. Am J Crit Care (2001) 1.36
Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage : a randomized controlled trial. Stroke (2000) 1.34
Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks. Cochrane Database Syst Rev (2007) 1.33
Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage. Neurology (2001) 1.33
Using modern information technology to profile faculty activities. Acad Med (1998) 1.32
Predictors of resource use after acute hospitalization: the Northern Manhattan Stroke Study. Neurology (2000) 1.31
Regulation of cartilage oligomeric matrix protein synthesis in human synovial cells and articular chondrocytes. Arthritis Rheum (1998) 1.30
Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy. J Urol (2001) 1.30
Validity of telephone interview data for vascular disease risk factors in a racially mixed urban community: the Northern Manhattan Stroke Study. Neuroepidemiology (1999) 1.29
Naringin and Neohesperidin Levels during Development of Leaves, Flower Buds, and Fruits of Citrus aurantium. Plant Physiol (1992) 1.27
Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias. Neurology (1997) 1.27
Leading UK paediatrician reinstated. BMJ (2001) 1.25
Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events. Am Heart J (2006) 1.24
The introduction of solids in relation to asthma and eczema. Arch Dis Child (2004) 1.24
No evidence for female-to-female HIV transmission among 960,000 female blood donors. The HIV Blood Donor Study Group. J Acquir Immune Defic Syndr (1992) 1.24
Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Database Syst Rev (2005) 1.24
Conflict-of-interest guidelines for a multicenter clinical trial of treatment after coronary-artery bypass-graft surgery. N Engl J Med (1989) 1.23
Effects of racist provocation and social support on cardiovascular reactivity in African American women. Int J Behav Med (1995) 1.22
Bcl-2 proteins regulate ER membrane permeability to luminal proteins during ER stress-induced apoptosis. Cell Death Differ (2010) 1.22
Lower prevalence of silent brain infarcts in the physically active: the Northern Manhattan Study. Neurology (2011) 1.22
End-of-life issues in intensive care units: a national random survey of nurses' knowledge and beliefs. Am J Crit Care (2001) 1.21
Differential regulation and expression of hyaluronan synthases in human articular chondrocytes, synovial cells and osteosarcoma cells. Biochem J (2001) 1.19
Impact of baseline symptom severity on future risk of benign prostatic hyperplasia-related outcomes and long-term response to finasteride. The Pless Study Group. Urology (2000) 1.19
Frequency and clinical determinants of dementia after ischemic stroke. Neurology (2000) 1.19
Oral contraceptives and breast disease. An epidemiological study. Am J Epidemiol (1978) 1.18
Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer. J Clin Oncol (2001) 1.18
Allelic variation in the vitamin D receptor, lifestyle factors and lumbar spinal degenerative disease. Ann Rheum Dis (1998) 1.16
Topical treatments for fungal infections of the skin and nails of the foot. Cochrane Database Syst Rev (2000) 1.16
Genealogical study of human twinning. Am J Public Health Nations Health (1965) 1.16
Enterococcus faecalis multi-drug resistance transporters: application for antibiotic discovery. J Mol Microbiol Biotechnol (2001) 1.16
Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure. Am J Cardiol (1977) 1.16
Voluntary anonymous linked study of the prevalence of HIV infection and hepatitis C among inmates in a Canadian federal penitentiary for women. CMAJ (1995) 1.16
Making hard choices easier: a prospective, multicentre study to assess the efficacy of a fertility-related decision aid in young women with early-stage breast cancer. Br J Cancer (2012) 1.15
Glycerol as substrate for the production of biosurfactant by Pseudomonas aeruginosa UCP0992. Colloids Surf B Biointerfaces (2010) 1.14
Autoimmune progesterone dermatitis. Arch Dermatol (1977) 1.12
Total homocysteine and cognition in a tri-ethnic cohort: the Northern Manhattan Study. Neurology (2004) 1.11
Risk factors for early recurrence after ischemic stroke: the role of stroke syndrome and subtype. Stroke (1998) 1.11